News Focus
News Focus
Followers 170
Posts 23224
Boards Moderated 1
Alias Born 12/09/2004

Re: 12x post# 496025

Sunday, 08/03/2025 9:55:10 PM

Sunday, August 03, 2025 9:55:10 PM

Post# of 519023
Why would there be doubt about a confirmatory trial, especially if the label restricts it to the 70% of the population that responded most strongly?

Conditional approval means the drug can be marketed. That means real revenues for Anavex.

It seems unlikely that the label would be restrictive in the first place.
Yeah the mutant type (30%) SIGMAR 1 does respond as well as the wild type. What is the other choice for the 30% ? Nothing!

It is a case of some is better than none and the 30% has no other real options.

Nunc est Bibendum

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News